|
 |
|
Insulin- Global
This package contains 63 insulin market analyses from the following countries: Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Spain, Sweden, Ukraine, the United Kingdom, Armenia, Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South Korea, Sri Lanka, Thailand, Turkey, Canada, Chile, Colombia, Ecuador, Mexico, Panama, Peru, the United States and Uruguay. The insulin market analyses give an overview of the actual situation, trends and future outlook of the insulin markets in different countries....
|
 |
|
$26661.00 |
| |
|
|
|
Vaccines - Global
This package contains 63 vaccine market analyses from the following countries: Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Spain, Sweden, Ukraine, the United Kingdom, Australia,Canada, Chile, Colombia, Ecuador, Eritrea, Mexico, Panama, Peru, United States, Uruguay, Armenia, Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South Korea, Sri Lanka, Thailand, Turkey, Ethiopia, Ghana, Morocco and Nigeria. The vaccine market analyses give an overview of the actual situation, trends and future outlook of the vaccine markets in different countries.
|
|
|
$26661.00 |
| |
|
|
|
Analytical Tool Antibodies and Peptides in Oncology
Analytical Tool – Antibodies and Peptides in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$22312.50 |
| |
|
|
|
Analytical Tool - Hematological Cancers
Analytical Tool – Hematological Cancers offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$22312.50 |
| |
|
|
|
Analytical Tool - Cancer Immunotherapy
Analytical Tool- Cancer Immunotherapy offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$20437.50 |
| |
|
|
|
Analytical Tool - Protein Kinase Inhibitors in Oncology
Analytical Tool - Protein Kinase Inhibitors in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$16683.75 |
| |
|
|
|
Oncology Drug Pathway Analyzer (Premium Version)
Get instant, interactive modeling on almost 3,000 cancer drugs and affected signaling pathways across close to 90 different cancer types. Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer....
|
|
|
$14850.00 |
| |
|
|
|
Analytical Tool - Cancer Therapeutic Antibodies
Analytical Tool - Cancer Therapeutic Antibodies offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$14808.75 |
| |
|
|
|
The 2011 Top Ten World's Leading Pharmaceutical Companies
A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs....
|
|
|
$13200.00 |
| |
|
|
|
Triple Analysis: Lymphoma, Prostate Cancer and Apoptosis
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology....
|
|
|
$12937.50 |
| |
|
|
|
Triple Analysis: Leukemia, Antibodies and Peptides
This triple analysis focuses on cancer drug development strategies in Leukemia and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology....
|
|
|
$12937.50 |
| |
|
|
|
Analytical Tool - Apoptosis in Oncology
Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Angiogenesis in Oncology
Analytical Tool - Angiogenesis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Colorectal Cancer
Analytical Tool - Colorectal Cancer offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Lung Cancer
Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2013". According to market analytical studies, the therapeutic lung cancer drug market is predicted to exceed $4 billion between 2010 and 2015....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Lymphoma
Analytical Tool: Lymphoma offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Pancreatic Cancer
Analytical Tool - Pancreatic Cancer offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
Analytical Tool - Breast Cancer
Analytical Tool - Breast Cancer offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future....
|
|
|
$11625.00 |
| |
|
|
|
|